AlloVir

0 followers

‌

AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.

Industries

Headquarters

Stage

Employees

Links

Org chart

View full screen

Diana M. Brainard

CEO

Diana M. Brainard

Collapse

President and Chief Financial Officer

Chief Scientific Officer

General Counsel

SVP of Technical Operations

SVP of CMC Operations

Chief Commercial Officer (cco)

Alicia Defrancesco

Senior Director, Head Of Commercial Strategy And Operations

Teams

View all

Board of Directors

5 members

Leadership Team

6 members

CEO and Executive Team

5 members

Discover similar companies

Coherus BioSciences

5 followers

Agilent Technologies

60 followers

Regeneron

77 followers

Verve Therapeutics

53 followers

Biogen

91 followers